nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Topotecan—cervical cancer	0.597	1	CiPCiCtD
Etoposide—uterine cancer—cervical cancer	0.277	1	CtDrD
Etoposide—ABCG2—Topotecan—cervical cancer	0.0522	0.634	CbGbCtD
Etoposide—ABCB1—Topotecan—cervical cancer	0.0188	0.229	CbGbCtD
Etoposide—CYP3A4—Topotecan—cervical cancer	0.0113	0.137	CbGbCtD
Etoposide—Acute leukaemia—Topotecan—cervical cancer	0.00187	0.0931	CcSEcCtD
Etoposide—Myelosuppression—Topotecan—cervical cancer	0.00114	0.0568	CcSEcCtD
Etoposide—Mucosal inflammation—Topotecan—cervical cancer	0.000964	0.0481	CcSEcCtD
Etoposide—TOP2A—Irinotecan—Topotecan—cervical cancer	0.000922	1	CbGdCrCtD
Etoposide—Febrile neutropenia—Topotecan—cervical cancer	0.000887	0.0442	CcSEcCtD
Etoposide—Interstitial lung disease—Topotecan—cervical cancer	0.000754	0.0376	CcSEcCtD
Etoposide—GSTP1—exocrine gland—cervical cancer	0.000712	0.0306	CbGeAlD
Etoposide—Rigors—Topotecan—cervical cancer	0.000654	0.0326	CcSEcCtD
Etoposide—GSTT1—renal system—cervical cancer	0.000623	0.0268	CbGeAlD
Etoposide—Extravasation—Topotecan—cervical cancer	0.000612	0.0305	CcSEcCtD
Etoposide—ABCC6—renal system—cervical cancer	0.000506	0.0217	CbGeAlD
Etoposide—Neuropathy—Topotecan—cervical cancer	0.000501	0.025	CcSEcCtD
Etoposide—GSTT1—female reproductive system—cervical cancer	0.000499	0.0215	CbGeAlD
Etoposide—TOP2B—uterine cervix—cervical cancer	0.00049	0.0211	CbGeAlD
Etoposide—Rash maculo-papular—Topotecan—cervical cancer	0.000485	0.0242	CcSEcCtD
Etoposide—TOP2B—decidua—cervical cancer	0.000467	0.0201	CbGeAlD
Etoposide—Sepsis—Topotecan—cervical cancer	0.000463	0.0231	CcSEcCtD
Etoposide—TOP2B—renal system—cervical cancer	0.000459	0.0197	CbGeAlD
Etoposide—TOP2B—endometrium—cervical cancer	0.000444	0.0191	CbGeAlD
Etoposide—TOP2B—mammalian vulva—cervical cancer	0.000429	0.0185	CbGeAlD
Etoposide—TOP2B—uterus—cervical cancer	0.000409	0.0176	CbGeAlD
Etoposide—Anaphylactoid reaction—Topotecan—cervical cancer	0.0004	0.02	CcSEcCtD
Etoposide—Cardiac arrest—Topotecan—cervical cancer	0.000368	0.0184	CcSEcCtD
Etoposide—TOP2B—female reproductive system—cervical cancer	0.000367	0.0158	CbGeAlD
Etoposide—UGT1A1—renal system—cervical cancer	0.000366	0.0157	CbGeAlD
Etoposide—TOP2A—uterine cervix—cervical cancer	0.000361	0.0155	CbGeAlD
Etoposide—Cramp muscle—Topotecan—cervical cancer	0.000349	0.0174	CcSEcCtD
Etoposide—TOP2A—decidua—cervical cancer	0.000344	0.0148	CbGeAlD
Etoposide—Alanine aminotransferase increased—Topotecan—cervical cancer	0.000342	0.017	CcSEcCtD
Etoposide—TOP2B—female gonad—cervical cancer	0.000334	0.0144	CbGeAlD
Etoposide—TOP2B—vagina—cervical cancer	0.000332	0.0143	CbGeAlD
Etoposide—TOP2A—endometrium—cervical cancer	0.000326	0.014	CbGeAlD
Etoposide—Pancytopenia—Topotecan—cervical cancer	0.000318	0.0159	CcSEcCtD
Etoposide—TOP2A—mammalian vulva—cervical cancer	0.000315	0.0136	CbGeAlD
Etoposide—Neutropenia—Topotecan—cervical cancer	0.000313	0.0156	CcSEcCtD
Etoposide—GSTP1—epithelium—cervical cancer	0.00031	0.0133	CbGeAlD
Etoposide—GSTP1—uterine cervix—cervical cancer	0.000307	0.0132	CbGeAlD
Etoposide—ABCC10—uterine cervix—cervical cancer	0.000307	0.0132	CbGeAlD
Etoposide—TOP2A—uterus—cervical cancer	0.000301	0.0129	CbGeAlD
Etoposide—Pneumonia—Topotecan—cervical cancer	0.0003	0.015	CcSEcCtD
Etoposide—Infestation—Topotecan—cervical cancer	0.000299	0.0149	CcSEcCtD
Etoposide—Infestation NOS—Topotecan—cervical cancer	0.000299	0.0149	CcSEcCtD
Etoposide—ABCC3—decidua—cervical cancer	0.000294	0.0126	CbGeAlD
Etoposide—Neuropathy peripheral—Topotecan—cervical cancer	0.000293	0.0146	CcSEcCtD
Etoposide—GSTP1—decidua—cervical cancer	0.000293	0.0126	CbGeAlD
Etoposide—ABCC10—decidua—cervical cancer	0.000292	0.0126	CbGeAlD
Etoposide—Stomatitis—Topotecan—cervical cancer	0.000291	0.0145	CcSEcCtD
Etoposide—ABCC3—renal system—cervical cancer	0.000289	0.0124	CbGeAlD
Etoposide—GSTP1—renal system—cervical cancer	0.000287	0.0124	CbGeAlD
Etoposide—ABCC10—renal system—cervical cancer	0.000287	0.0124	CbGeAlD
Etoposide—Hepatobiliary disease—Topotecan—cervical cancer	0.000282	0.0141	CcSEcCtD
Etoposide—GSTP1—endometrium—cervical cancer	0.000278	0.012	CbGeAlD
Etoposide—ABCC10—endometrium—cervical cancer	0.000278	0.0119	CbGeAlD
Etoposide—GSTP1—mammalian vulva—cervical cancer	0.000269	0.0116	CbGeAlD
Etoposide—ABCC10—mammalian vulva—cervical cancer	0.000269	0.0116	CbGeAlD
Etoposide—Hypoaesthesia—Topotecan—cervical cancer	0.000267	0.0133	CcSEcCtD
Etoposide—GSTP1—uterus—cervical cancer	0.000256	0.011	CbGeAlD
Etoposide—ABCC10—uterus—cervical cancer	0.000256	0.011	CbGeAlD
Etoposide—TOP2A—female gonad—cervical cancer	0.000246	0.0106	CbGeAlD
Etoposide—TOP2A—vagina—cervical cancer	0.000244	0.0105	CbGeAlD
Etoposide—Angiopathy—Topotecan—cervical cancer	0.000243	0.0121	CcSEcCtD
Etoposide—Immune system disorder—Topotecan—cervical cancer	0.000242	0.0121	CcSEcCtD
Etoposide—Mediastinal disorder—Topotecan—cervical cancer	0.000242	0.012	CcSEcCtD
Etoposide—Chills—Topotecan—cervical cancer	0.000241	0.012	CcSEcCtD
Etoposide—Alopecia—Topotecan—cervical cancer	0.000237	0.0118	CcSEcCtD
Etoposide—ABCC3—female reproductive system—cervical cancer	0.000231	0.00994	CbGeAlD
Etoposide—ABCC2—renal system—cervical cancer	0.000231	0.00992	CbGeAlD
Etoposide—GSTP1—female reproductive system—cervical cancer	0.00023	0.0099	CbGeAlD
Etoposide—ABCC10—female reproductive system—cervical cancer	0.00023	0.00989	CbGeAlD
Etoposide—Back pain—Topotecan—cervical cancer	0.000226	0.0113	CcSEcCtD
Etoposide—Muscle spasms—Topotecan—cervical cancer	0.000224	0.0112	CcSEcCtD
Etoposide—ABCC1—uterine cervix—cervical cancer	0.000217	0.00934	CbGeAlD
Etoposide—Ill-defined disorder—Topotecan—cervical cancer	0.000217	0.0108	CcSEcCtD
Etoposide—Anaemia—Topotecan—cervical cancer	0.000216	0.0108	CcSEcCtD
Etoposide—TOP2B—lymph node—cervical cancer	0.000215	0.00925	CbGeAlD
Etoposide—Malaise—Topotecan—cervical cancer	0.00021	0.0105	CcSEcCtD
Etoposide—ABCC3—female gonad—cervical cancer	0.00021	0.00905	CbGeAlD
Etoposide—GSTP1—female gonad—cervical cancer	0.000209	0.00901	CbGeAlD
Etoposide—ABCC10—female gonad—cervical cancer	0.000209	0.009	CbGeAlD
Etoposide—Leukopenia—Topotecan—cervical cancer	0.000209	0.0104	CcSEcCtD
Etoposide—GSTP1—vagina—cervical cancer	0.000208	0.00895	CbGeAlD
Etoposide—ABCC10—vagina—cervical cancer	0.000208	0.00895	CbGeAlD
Etoposide—ABCC1—decidua—cervical cancer	0.000207	0.0089	CbGeAlD
Etoposide—Cough—Topotecan—cervical cancer	0.000204	0.0102	CcSEcCtD
Etoposide—Chest pain—Topotecan—cervical cancer	0.000199	0.00991	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000197	0.00984	CcSEcCtD
Etoposide—ABCC1—endometrium—cervical cancer	0.000196	0.00845	CbGeAlD
Etoposide—Discomfort—Topotecan—cervical cancer	0.000196	0.00979	CcSEcCtD
Etoposide—Anaphylactic shock—Topotecan—cervical cancer	0.00019	0.0095	CcSEcCtD
Etoposide—ABCC1—mammalian vulva—cervical cancer	0.00019	0.00817	CbGeAlD
Etoposide—Infection—Topotecan—cervical cancer	0.000189	0.00944	CcSEcCtD
Etoposide—Thrombocytopenia—Topotecan—cervical cancer	0.000186	0.0093	CcSEcCtD
Etoposide—Skin disorder—Topotecan—cervical cancer	0.000185	0.00922	CcSEcCtD
Etoposide—ABCC2—female reproductive system—cervical cancer	0.000185	0.00794	CbGeAlD
Etoposide—Hyperhidrosis—Topotecan—cervical cancer	0.000184	0.00918	CcSEcCtD
Etoposide—Anorexia—Topotecan—cervical cancer	0.000182	0.00905	CcSEcCtD
Etoposide—ABCC1—uterus—cervical cancer	0.000181	0.00778	CbGeAlD
Etoposide—ABCG2—uterine cervix—cervical cancer	0.00018	0.00773	CbGeAlD
Etoposide—CYP2C8—renal system—cervical cancer	0.000173	0.00744	CbGeAlD
Etoposide—ABCG2—decidua—cervical cancer	0.000171	0.00737	CbGeAlD
Etoposide—Paraesthesia—Topotecan—cervical cancer	0.000171	0.00853	CcSEcCtD
Etoposide—Dyspnoea—Topotecan—cervical cancer	0.00017	0.00847	CcSEcCtD
Etoposide—CYP2C8—endometrium—cervical cancer	0.000167	0.00719	CbGeAlD
Etoposide—CYP3A5—uterine cervix—cervical cancer	0.000167	0.00718	CbGeAlD
Etoposide—Decreased appetite—Topotecan—cervical cancer	0.000166	0.00826	CcSEcCtD
Etoposide—Gastrointestinal disorder—Topotecan—cervical cancer	0.000164	0.0082	CcSEcCtD
Etoposide—Fatigue—Topotecan—cervical cancer	0.000164	0.00819	CcSEcCtD
Etoposide—Pain—Topotecan—cervical cancer	0.000163	0.00812	CcSEcCtD
Etoposide—Constipation—Topotecan—cervical cancer	0.000163	0.00812	CcSEcCtD
Etoposide—ABCG2—endometrium—cervical cancer	0.000163	0.00699	CbGeAlD
Etoposide—CYP1A2—renal system—cervical cancer	0.000162	0.00696	CbGeAlD
Etoposide—TOP2A—lymph node—cervical cancer	0.000158	0.0068	CbGeAlD
Etoposide—ABCG2—mammalian vulva—cervical cancer	0.000157	0.00676	CbGeAlD
Etoposide—Feeling abnormal—Topotecan—cervical cancer	0.000157	0.00783	CcSEcCtD
Etoposide—CYP3A5—renal system—cervical cancer	0.000156	0.00671	CbGeAlD
Etoposide—Gastrointestinal pain—Topotecan—cervical cancer	0.000156	0.00777	CcSEcCtD
Etoposide—Urticaria—Topotecan—cervical cancer	0.000151	0.00754	CcSEcCtD
Etoposide—PTGS1—epithelium—cervical cancer	0.000151	0.0065	CbGeAlD
Etoposide—Body temperature increased—Topotecan—cervical cancer	0.000151	0.00751	CcSEcCtD
Etoposide—Abdominal pain—Topotecan—cervical cancer	0.000151	0.00751	CcSEcCtD
Etoposide—PTGS1—uterine cervix—cervical cancer	0.00015	0.00645	CbGeAlD
Etoposide—ABCG2—uterus—cervical cancer	0.00015	0.00644	CbGeAlD
Etoposide—ABCC1—female gonad—cervical cancer	0.000148	0.00637	CbGeAlD
Etoposide—ABCC1—vagina—cervical cancer	0.000147	0.00633	CbGeAlD
Etoposide—CYP2E1—renal system—cervical cancer	0.000146	0.00626	CbGeAlD
Etoposide—PTGS2—epithelium—cervical cancer	0.000145	0.00622	CbGeAlD
Etoposide—PTGS2—uterine cervix—cervical cancer	0.000143	0.00616	CbGeAlD
Etoposide—Hypersensitivity—Topotecan—cervical cancer	0.00014	0.007	CcSEcCtD
Etoposide—PTGS1—renal system—cervical cancer	0.00014	0.00603	CbGeAlD
Etoposide—CYP2C8—female reproductive system—cervical cancer	0.000138	0.00596	CbGeAlD
Etoposide—Asthenia—Topotecan—cervical cancer	0.000137	0.00681	CcSEcCtD
Etoposide—PTGS1—endometrium—cervical cancer	0.000136	0.00583	CbGeAlD
Etoposide—ABCC3—lymph node—cervical cancer	0.000135	0.00582	CbGeAlD
Etoposide—Pruritus—Topotecan—cervical cancer	0.000135	0.00672	CcSEcCtD
Etoposide—GSTP1—lymph node—cervical cancer	0.000135	0.00579	CbGeAlD
Etoposide—ABCC10—lymph node—cervical cancer	0.000135	0.00579	CbGeAlD
Etoposide—PTGS2—renal system—cervical cancer	0.000134	0.00577	CbGeAlD
Etoposide—PTGS1—mammalian vulva—cervical cancer	0.000131	0.00564	CbGeAlD
Etoposide—Diarrhoea—Topotecan—cervical cancer	0.00013	0.0065	CcSEcCtD
Etoposide—PTGS2—endometrium—cervical cancer	0.00013	0.00557	CbGeAlD
Etoposide—Dizziness—Topotecan—cervical cancer	0.000126	0.00628	CcSEcCtD
Etoposide—CYP2C8—vagina—cervical cancer	0.000125	0.00539	CbGeAlD
Etoposide—PTGS1—uterus—cervical cancer	0.000125	0.00537	CbGeAlD
Etoposide—ABCG2—female gonad—cervical cancer	0.000123	0.00527	CbGeAlD
Etoposide—ABCG2—vagina—cervical cancer	0.000122	0.00524	CbGeAlD
Etoposide—Vomiting—Topotecan—cervical cancer	0.000121	0.00604	CcSEcCtD
Etoposide—Rash—Topotecan—cervical cancer	0.00012	0.00599	CcSEcCtD
Etoposide—Dermatitis—Topotecan—cervical cancer	0.00012	0.00598	CcSEcCtD
Etoposide—PTGS2—uterus—cervical cancer	0.000119	0.00514	CbGeAlD
Etoposide—Headache—Topotecan—cervical cancer	0.000119	0.00595	CcSEcCtD
Etoposide—CYP3A4—renal system—cervical cancer	0.000117	0.00504	CbGeAlD
Etoposide—CYP2E1—female reproductive system—cervical cancer	0.000117	0.00502	CbGeAlD
Etoposide—CYP3A5—female gonad—cervical cancer	0.000114	0.00489	CbGeAlD
Etoposide—Nausea—Topotecan—cervical cancer	0.000113	0.00564	CcSEcCtD
Etoposide—CYP3A5—vagina—cervical cancer	0.000113	0.00486	CbGeAlD
Etoposide—PTGS1—female reproductive system—cervical cancer	0.000112	0.00483	CbGeAlD
Etoposide—ABCC2—lymph node—cervical cancer	0.000108	0.00465	CbGeAlD
Etoposide—PTGS2—female reproductive system—cervical cancer	0.000107	0.00462	CbGeAlD
Etoposide—PTGS1—female gonad—cervical cancer	0.000102	0.0044	CbGeAlD
Etoposide—PTGS1—vagina—cervical cancer	0.000102	0.00437	CbGeAlD
Etoposide—PTGS2—female gonad—cervical cancer	9.77e-05	0.0042	CbGeAlD
Etoposide—PTGS2—vagina—cervical cancer	9.71e-05	0.00418	CbGeAlD
Etoposide—ABCC1—lymph node—cervical cancer	9.52e-05	0.00409	CbGeAlD
Etoposide—CYP3A4—female reproductive system—cervical cancer	9.38e-05	0.00404	CbGeAlD
Etoposide—ABCB1—epithelium—cervical cancer	8.94e-05	0.00385	CbGeAlD
Etoposide—ABCB1—uterine cervix—cervical cancer	8.86e-05	0.00381	CbGeAlD
Etoposide—ABCB1—decidua—cervical cancer	8.44e-05	0.00363	CbGeAlD
Etoposide—ABCB1—renal system—cervical cancer	8.29e-05	0.00357	CbGeAlD
Etoposide—ABCB1—endometrium—cervical cancer	8.02e-05	0.00345	CbGeAlD
Etoposide—ABCG2—lymph node—cervical cancer	7.88e-05	0.00339	CbGeAlD
Etoposide—ABCB1—mammalian vulva—cervical cancer	7.75e-05	0.00334	CbGeAlD
Etoposide—ABCB1—uterus—cervical cancer	7.39e-05	0.00318	CbGeAlD
Etoposide—ABCB1—female reproductive system—cervical cancer	6.64e-05	0.00286	CbGeAlD
Etoposide—PTGS1—lymph node—cervical cancer	6.57e-05	0.00283	CbGeAlD
Etoposide—PTGS2—lymph node—cervical cancer	6.28e-05	0.0027	CbGeAlD
Etoposide—ABCB1—female gonad—cervical cancer	6.04e-05	0.0026	CbGeAlD
Etoposide—ABCB1—vagina—cervical cancer	6.01e-05	0.00258	CbGeAlD
Etoposide—ABCB1—lymph node—cervical cancer	3.88e-05	0.00167	CbGeAlD
